Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure
Authors
Keywords
MIBG cardiac imaging, Low-dose protocol, Planar, Single-photon emission computed tomography, Reproducibility
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 40, Issue 10, Pages 1549-1557
Publisher
Springer Nature
Online
2013-06-05
DOI
10.1007/s00259-013-2461-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
- (2012) Caroline E. Veltman et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tracking a therapeutic response: How reliable are serial measurements of LV perfusion and function?
- (2012) Guido Germano et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Cardiac autonomic imaging with SPECT tracers
- (2012) Mark I. Travin JOURNAL OF NUCLEAR CARDIOLOGY
- Determination of the survival rate in patients with congestive heart failure stratified by 123I-MIBG imaging: a meta-analysis from the studies performed in Japan
- (2011) Yoichi Kuwabara et al. ANNALS OF NUCLEAR MEDICINE
- Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study
- (2011) Kenichi Nakajima et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal
- (2011) P. Perrone-Filardi et al. HEART
- Cardiac Sympathetic Dysfunction in Genotyped Patients with Arrhythmogenic Right Ventricular Cardiomyopathy and Risk of Recurrent Ventricular Tachyarrhythmias
- (2011) M. Paul et al. JOURNAL OF NUCLEAR MEDICINE
- Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology
- (2010) Albert Flotats et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed
- (2010) Jan Kottner et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients
- (2010) Mark J. Boogers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure
- (2010) Arnold F. Jacobson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Method agreement analysis: A review of correct methodology
- (2010) P.F. Watson et al. THERIOGENOLOGY
- Cardiac Sympathetic Imaging With mIBG in Heart Failure
- (2010) Ignasi Carrió et al. JACC-Cardiovascular Imaging
- Myocardial Sympathetic Innervation and Long-Term Left Ventricular Mechanical Unloading
- (2010) Stavros G. Drakos et al. JACC-Cardiovascular Imaging
- The Sympathetic Nervous System in Heart Failure
- (2009) Filippos Triposkiadis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera–collimator combinations
- (2008) Shinro Matsuo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
- (2008) S. Kasama et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started